Laboratory Infection

Accidentally acquired infection in laboratory workers.

Also Known As:

Infection, Laboratory; Infections, Laboratory; Laboratory Infections

Networked: 80 relevant articles (1 outcomes, 10 trials/studies)

Relationship Network

Disease Context: Research Results

Related Diseases

1.	Infections
2.	Hepatitis C
3.	Substance-Related Disorders (Drug Abuse)
4.	Plague (Bubonic Plague)
5.	Neoplasms (Cancer)

Experts

1.	Holmes, Danalyn R: 1 article (10/2023)
2.	Horvath, Diana M: 1 article (10/2023)
3.	Jones, Jeffrey B: 1 article (10/2023)
4.	Lahaye, Thomas: 1 article (10/2023)
5.	Minsavage, Gerald V: 1 article (10/2023)
6.	Moore, Gloria A: 1 article (10/2023)
7.	Orbović, Vladimir: 1 article (10/2023)
8.	Römer, Patrick: 1 article (10/2023)
9.	Shantharaj, Deepak: 1 article (10/2023)
10.	Adams, Madison E: 1 article (06/2023)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Laboratory Infection:

1.	ImmunosorbentsIBA 07/01/2003 - "The established enzyme-linked immunosorbent assay therefore has the ability to become a very useful tool for obtaining an accurate diagnosis in the field, limiting the risk of laboratory infections."
2.	EnzymesIBA 07/01/2003 - "The established enzyme-linked immunosorbent assay therefore has the ability to become a very useful tool for obtaining an accurate diagnosis in the field, limiting the risk of laboratory infections."
3.	Streptomycin (Streptomycin Sulfate)FDA Link 02/01/1947 - "Streptomycin in surgical infections; laboratory studies." 01/01/1956 - "[Laboratory infection with Mycobacterium tuberculosis which showed reduced sensitivity toward streptomycin and isoniazid]."
4.	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/01/2018 - " no evidence of infection, laboratory findings revealed leukocytosis and high serum levels of granulocyte-colony stimulating factor(G-CSF).An immunohistochemical study showed positive staining for G-CSF in the tumor cells.Chemoradiation"
5.	Viral RNAIBA 01/01/2017 - "The studies were conducted in a variety of CJ settings and collected information across 11 pre-selected domains: demographic characteristics, CJ involvement, HIV risk behaviors, HIV and/or Hepatitis C infections, laboratory measures of CD4 T-cell count (CD4) and HIV RNA viral load (VL), mental illness, health related quality of life (QoL), socioeconomic status, health care access, substance use, and social support. "
6.	DNA (Deoxyribonucleic Acid)IBA 01/01/2015 - "Here, five examples are summarized: (i) smallpox virus escaped from a UK laboratory where it was being maintained and stored, (ii) the 2014 infections and deaths of five researchers who were isolating West African Ebola virus for DNA sequencing epidemiology studies, (iii) and (iv) two recent infections that happened in the same US laboratory where researchers were infected with agents causing septicemic Yersinia plague and Bacillus anthrax and (v) the 2012 death in California from laboratory infection by Neisseria meningitidis resulting in spinal meningitis. "
7.	Cephalexin (Cefalexin)FDA LinkGeneric 10/01/1970 - "Cephalexin in chronic and recurrent urinary infections: laboratory and clinical studies."
8.	Amikacin (A.M.K)FDA LinkGeneric 11/01/1976 - "Amikacin in obstetric, gynecologic, and neonatal infections: laboratory and clinical studies."
9.	selamectinIBA 08/23/2000 - "In the natural infection laboratory studies, when selamectin was administered twice at an interval of 30 days, the percentage reductions in geometric mean numbers of adult T. "
10.	8- (4- carboxymethyloxy)phenyl- 1,3- dipropylxanthineIBA 10/01/2023 - "Finally, we show that the Xcc-TALE-trap confers resistance not only in laboratory infection assays but also in more agriculturally relevant field studies. "

Therapies and Procedures

1.	Duration of Therapy 09/01/2009 - "Parameters recorded included: demographics, past medical history, predisposing factors, presenting signs and symptoms, spinal level and extension of the infection, laboratory indices of inflammation, microbiological testing, radiological assessment, kind and duration of treatment, follow-up magnetic resonance imaging (MRI) studies, and outcome. " 09/01/2021 - "The potential determinants of antibiotic treatment duration addressed in all scenarios included clinical variables (patient characteristics, disease severity), laboratory infection markers, radiologic findings, and pathogens. "
2.	Oral Hygiene (Dental Hygiene) 05/01/1993 - "Since Pennsylvania dental hygienists, within the limitations of this study, appear not to follow CDC guidelines on proper and responsible operatory/laboratory aseptic techniques stringently, and to differentiate infection control procedures based on perceived patient HIV status, recommendations are that 1) the Commonwealth of Pennsylvania should mandate that all Pennsylvania-licensed dental hygienists take at least one state-approved course on operatory/laboratory infection control every two years to qualify for relicensure; 2) all dental and dental hygiene education institutions and professional organizations should place more emphasis on strict adherence to the various agency recommended clinical guidelines for infection control; and 3) all dental hygienists should continually strive to update their own knowledge of current infection control practices."
3.	Therapeutics 07/01/2008 - "As novel therapies are developed that target virus-infected cells or overcome the adverse effects of infection, laboratory testing becomes even more critical for determining when intervention is appropriate and the extent to which it has succeeded." 11/01/1982 - "Reports describing small numbers of patients or individual cases have documented the failure of therapy in clinical and laboratory infections caused by both sensitive or resistant anaerobic bacteria. "
4.	Drug Therapy (Chemotherapy) 01/01/1985 - "The first described the different members of the herpesvirus group, clinical expression of infection, laboratory diagnosis, and chemotherapy. " 06/01/2020 - "The clinical data of 133 children with ALL treated with CCCG-ALL-2015 from June 2016 to June 2019 (chemotherapy stage, risk level, MRD), infection during hospitalization (course of infection, laboratory indicators, sites of infection, outcome) and nutritional status (sex, age, height/ length, weight) were enrolled. "
5.	Hand Hygiene 01/01/2020 - "We explore its potential IPC benefits in epidemiology, laboratory infection diagnosis, and hand hygiene. "